Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 24, Number 42, 2017

Editorial

Free Content Editorial: Recent Trends in Anticancer Drug Development: Challenges and Opportunities
pp. 4727-4728(2)
Authors: Skvortsova, Ira-Ida; Kumar, Vinod

Favourites:
ADD

Review article

Promising Targets in Anti-cancer Drug Development: Recent Updates
pp. 4729-4752(24)
Authors: Kumar, Bhupinder; Singh, Sandeep; Skvortsova, Ira; Kumar, Vinod

Favourites:
ADD

Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches
pp. 4753-4778(26)
Authors: Basith, Shaherin; Cui, Minghua; Macalino, Stephani J.Y.; Choi, Sun

Favourites:
ADD

Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues
pp. 4779-4799(21)
Authors: Fedorov, Sergey N.; Stonik, Valentin A.; Honecker, Friedemann; Dyshlovoy, Sergey A.

Favourites:
ADD

Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells
pp. 4800-4815(16)
Authors: Barrera, Giuseppina; Daga, Martina; Ferrara, Benedetta; Dianzani, Chiara; Pizzimenti, Stefania; Argenziano, Monica; Cavalli, Roberta; Trotta, Francesco

Favourites:
ADD

Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells
pp. 4816-4837(22)
Authors: Prunk, Mateja; Kos, Janko

Favourites:
ADD
Favourites:
ADD

Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy
pp. 4905-4950(46)
Authors: ReeƦ#159;ing, Friederike; Szymanski, Wiktor

Favourites:
ADD

Articles

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content